<DOC>
	<DOC>NCT02019394</DOC>
	<brief_summary>To determine the absolute bioavailability of the Lu AE58054 tablet formulation at steady state</brief_summary>
	<brief_title>Absolute Bioavailability of Lu AE58054 in Healthy Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy men and women aged between 2155 years (inclusive) and with an BMI in the range 18.5 to 32 kg/m2 (minimum weight 60 kg for men and 55 kg for women). The subjects CYP2D6 genotype must be determined before inclusion into the study. Women must not be pregnant or lactating. The subject is, in the opinion of the investigator, unlikely to comply with the protocol or is unsuitable for any reason. Other inclusion and exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>